Clinical Trial Update: R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of R-ICE and high-dose cyclophosphamide with PET/CT for diffuse large B-cell non-Hodgkin's lymphoma was terminated; results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• R-ICE
• cyclophosphamide (high-dose) (cyclophosphamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2018-09-25